Howson Tamar D
SEC-identified person · CIK 1202286 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vital Therapies INC VTL | Director | filed 2019 - 2026 |
| MEI Pharma, Inc. MSHL | Director | filed 2019 - 2023 |
| Cue Biopharma, Inc. CUE | Director | filed 2020 - 2023 |
| Vivosim Labs, INC. VIVS | Director | filed 2013 - 2018 |
| Hepion Pharmaceuticals, Inc. HEPA | Director | filed 2016 - 2017 |
| Oncotelic Therapeutics, Inc. OXGN | Director | filed 2010 - 2015 |
| Allergan plc AGN | Director | filed 2013 - 2015 |
| Idenix Pharmaceuticals INC IDIX | Director | filed 2010 - 2014 |
| Warner Chilcott plc WCRX | Director | filed 2013 - 2013 |
| Aradigm Corp ARDM | Director | filed 2010 - 2012 |
| Soligenix, INC. SNGX.OB | Director | filed 2010 - 2011 |
| Lexicon Pharmaceuticals, INC./DE LXRX | EVP of Bus Dev | filed 2007 - 2008 |
| Bristol Myers Squibb CO BMY | SVP, Corp & Bus Development | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.